# The Health Service Medicines (Control of Prices of Specified Generic Medicines) Regulations 2000, Regulation 2: Interpretation


(1) In these Regulations—
“the list of controlled prices” means the list of prices which was published on the internet at http://www.doh.gov.uk/generics on 6th July 2000 by the Department of Health;
“marketing authorisation” means a marketing authorisation for a medicinal product for human use granted—
(a) by the competent authorities of the United Kingdom in accordance with Council Directive 65/65/EEC of 26th January 1965 on the approximation of provisions laid down by law, regulation or administrative action relating to medicinal products; or
(b) by the European Agency for the Evaluation of Medicinal Products in accordance with Council Regulation (EEC) No. 2309/93 of 22nd July 1993 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Agency for the Evaluation of Medicinal Products;
“presentation” means a particular form of a medicine which may be distinguished from other forms of that medicine by reference to pack size;
“price”, except in the expressions “specified price” and “maximum price”, means the actual cost of acquiring a presentation of a specified generic medicine;
“specified generic medicine” means a health service medicine which—
(a) is listed in column (1) of the list of controlled prices notwithstanding the addition of a manufacturer’s or supplier’s name or trade mark; but
(b) is not identifiable by and traded under a specific name given to it by any person who is the manufacturer, supplier or holder of a marketing authorisation relating to it;
“specified price” in relation to a presentation of a specified generic medicine means the price specified in column (3) of the list of controlled prices opposite the medicine and presentation in question specified in columns (1) and (2);
“supply” means supply by way of sale to a person lawfully conducting a retail pharmacy business or to a registered medical practitioner, in order to enable that person or practitioner (as the case may be) to provide pharmaceutical services within the meaning of—
(a) section 41 of the National Health Service Act 1977 in England or Wales;
(b) section 27 of the National Health Service (Scotland) Act 1978 in Scotland; and
(c) article 63 of the Health and Personal Social Services (Northern Ireland) Order 1972 in Northern Ireland.
(2) A specified generic medicine is supplied on the date on which a contract for its sale for health service use is concluded.
(3) Any reference in these Regulations to a numbered regulation or Schedule is a reference to a regulation or Schedule which bears that number in these Regulations and any reference to a numbered paragraph in a regulation is a reference to the paragraph in that regulation which bears that number, unless the context otherwise requires.

---
Source: https://www.legislation.gov.uk/uksi/2000/1763/regulation/2 (the official version)
Page: https://openlegislation.uk/health-service-medicines-control-of-prices-of-specified-generic-medicines-regulations-2000/regulation-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

